JAMA Internal Medicine

X @jamainternalmed

⚔ Compare ☆ Follow Own this channel?

🔄 Data last refreshed 2 days ago

🤝

Make a deal with JAMA Internal Medicine

🔒 Paid proposals held safely in escrow — released only when the work's approved.

Followers

109.5K

Posts

30.5K

Following

478

Account age

17 yrs

🎁 Free analysisfor JAMA Internal Medicine

🕵️Fake Followers CheckReal-audience % & bot risk→ 📊Engagement rateBenchmarked vs. peers→ 💰What they chargeFair sponsored-post price→

Known for

137.7K views Metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. https://t.co/JMxHHQmh7y

Most viewed in the last 7 days from @JAMAInternalMed:

Clinical Insights by @TimAndersonMD and @ZacharyGJacobs proposes a new framework for managing asymptomatic blood pressure elevation in the hospital setting.

https://t.co/eL6mzsX8xn

85.9K views Most viewed in the last 7 days from @JAMAInternalMed: Clinical Insights by @TimAndersonMD and @ZacharyGJacobs proposes a new framework for managing asymptomatic blood pressure elevation in the hospital setting. https://t.co/eL6mzsX8xn

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a lower risk of #COPD exacerbations compared to DPP-4 inhibitors in patients with type 2 #diabetes and COPD. https://t.co/oWj3L8HfS3 @avikray_md, @wbfeldman

82.4K views SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a lower risk of #COPD exacerbations compared to DPP-4 inhibitors in patients with type 2 #diabetes and COPD. https://t.co/oWj3L8HfS3 @avikray_md, @wbfeldman

Shorter durations of #antibiotic prophylaxis, including no prophylaxis, appear noninferior to longer durations for preventing mortality in patients with #cirrhosis and upper gastrointestinal bleeding.

https://t.co/mjtAuyryYf

@bradspellberg @DrToddLee

26.4K views Shorter durations of #antibiotic prophylaxis, including no prophylaxis, appear noninferior to longer durations for preventing mortality in patients with #cirrhosis and upper gastrointestinal bleeding. https://t.co/mjtAuyryYf @bradspellberg @DrToddLee

📊 Post performance

40.6K

Avg views / post

37.1%

Reach vs followers

Jul 2009

On X since

🔥 Top post: Study findings do not support the treatment of elevated inpatien · 313.6K views

📊 Activity & format

Posting cadence

0.04 / week

A lower-frequency account — each post lands with more weight.

Content mix

Mostly images

Recent: 0 video · 11 image · 7 text.

Follower / following

229×

Follows 478 back. A strong ratio — an audience that follows them, not a follow-for-follow network.

Recent posts

View on X ↗

🔥 Top post Study findings do not support the treatment of elevated inpatient blood pressures in hospitalized older adults without evidence of end organ damage and highlight the need for randomized clinical trials of inpatient blood pressure treatment targets. 313.6K❤ 445🔁 198

Shorter durations of #antibiotic prophylaxis, including no prophylaxis, appear noninferior to longer durations for preventing mortality in patients with #cirrhosis and upper gastrointestinal bleeding. https://t.co/rV6MdyCGOQ @bradspellberg… 18.9K❤ 182🔁 64

Denosumab offers a convenient alternative to bisphosphonates for osteoporosis treatment but carries risks such as rebound fractures upon discontinuation. https://t.co/LTChfUKnQY 19.1K❤ 271🔁 77

Denosumab offers a convenient alternative to bisphosphonates for osteoporosis treatment but carries risks such as rebound fractures upon discontinuation. https://t.co/0PHfZTkUCu 16.8K❤ 195🔁 59

SGLT-2 inhibitors and GLP-1 receptor agonists are linked to a lower risk of #COPD exacerbations compared to DPP-4 inhibitors in patients with type 2 #diabetes and COPD. https://t.co/oWj3L8HfS3 @avikray_md, @wbfeldman 82.4K❤ 225🔁 55

Most viewed in the last 7 days from @JAMAInternalMed: Vitamin K2 supplementation significantly reduced the frequency, intensity, and duration of nocturnal leg cramps in an older population with good safety. https://t.co/dOdjpmsdYk 17K❤ 162🔁 56

Metformin was associated with a lower rate of asthma attacks, with further reductions with the use of GLP-1RA. https://t.co/JMxHHQmh7y 137.7K❤ 182🔁 59

Most viewed in the last 7 days from @JAMAInternalMed: Clinical Insights by @TimAndersonMD and @ZacharyGJacobs proposes a new framework for managing asymptomatic blood pressure elevation in the hospital setting. https://t.co/eL6mzsX8xn 85.9K❤ 195🔁 55 JAMA Internal Medicine introduces a new series, the Guide to Statistics and Methods, to be accessible to clinicians and researchers contextualizing and interpreting statistical methods applied in studies published in JAMA Internal Medicine… 40.6K❤ 281🔁 99 Findings suggest that older patients, particularly those with limited autonomy, who spend the night in the ED awaiting hospital admission may have a higher risk of in-hospital mortality and morbidity; they should be prioritized for admissi… 201.4K❤ 215🔁 111 In this randomized clinical trial, a 5-day course of oral ivermectin administered during the first week of #COVID19 illness did not reduce the risk of developing severe disease, when compared with standard of care alone. ❤ 155🔁 141

💡 Facts

🗓️Joined X in 2009 — 17 years ago.

👁️Averages 40.6K views per post.

📤Posts about 0× per week.

💬0.32% engagement rate.

🏅Earned the 100K Followers for passing 100K followers.

🕵️ Fake follower check

Estimated

37/100

Low Credibility score

66%

Mixed Real audience

Medium Fake-follower risk

High Data confidence

Est. 66% real, active audience · Medium fake-follower risk.
Low engagement (~0.4× of followers engage each post) — a sign of an inflated or inactive audience.
Organic base — far more followers than accounts it follows.
Established account (17+ years old).
0.32% engagement — below the ~14.4% typical for this size.

Heuristic estimate from engagement, follower ratios, account age & growth — a screening signal, not a guarantee.

About

JAMA Internal Medicine is a member of the JAMA Network, a consortium of peer-reviewed, general medical and specialty publications.

📸 Gallery

$Denosumab offers a convenient alternative to bisphosphonates for osteoporosis treatment but carries risks such as rebound fractures upon discontinuation. https://t.co/LTChfUKnQY$ $Denosumab offers a convenient alternative to bisphosphonates for osteoporosis treatment but carries risks such as rebound fractures upon discontinuation. https://t.co/0PHfZTkUCu$

🔀 Audience overlap

Estimated

Estimated shared audience with similar creators — useful for avoiding overlap (or doubling down) when planning a campaign.

Oleksandra Matviichuk 17%

Alt News 15%

Grayson Waller 13%

EA Japan 13%

Dr Dinesh Sharma BJP 12%

ローソン・ユナイテッドシネマ公式 11%

More like this

Find more →

X ＋

Dr Dinesh Sharma BJP ✓

Oleksandra Matviichuk ✓

@avalaina

197.4K Followers

Frequently asked questions

How much does JAMA Internal Medicine charge for a sponsorship?

JAMA Internal Medicine hasn't published fixed prices yet. Send a proposal through SocialDB and agree terms directly — your payment is held in escrow until the work is approved.

How do I contact JAMA Internal Medicine for a brand deal or collaboration?

Send a paid deal or collab request right here on SocialDB — we notify JAMA Internal Medicine, and once they accept, your payment is held safely in escrow and released when the work is approved. You don't need to track down an email.

How many followers does JAMA Internal Medicine have?

JAMA Internal Medicine has 109,501 followers on X.

Auto-generated from X's public data — no affiliation with or endorsement by SocialDB. Is this you? Claim it · Remove